MENU
NRSN
AS OF
Nov 28 closing price
Price
$1.19
Change
+$0.02 (+1.71%)
Capitalization
35.34M
115 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
NRSN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

NeuroSense Therapeutics (NRSN) Earnings Date & Reports

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases... Show more

A.I. Advisor
published Earnings

NRSN is expected to report earnings to fall 4.81% to -4 cents per share on March 25

NeuroSense Therapeutics NRSN Stock Earnings Reports
Q4'25
Est.
$-0.04
Q3'25
Beat
by $0.01
Q2'25
Beat
by $0.09
Q1'25
Beat
by $0.04
Q4'24
Missed
by $0.46
The last earnings report on November 26 showed earnings per share of -4 cents, beating the estimate of -5 cents. With 70.83K shares outstanding, the current market capitalization sits at 35.34M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
NRSN
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NRSN showed earnings on November 26, 2025. You can read more about the earnings report here.
View AI-Driven Trading for NRSN
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
11 HaMenofim Street, Building B
Phone
+972 97996183
Employees
14
Web
https://www.neurosense-tx.com